首页> 美国卫生研究院文献>Italian Journal of Pediatrics >Management of plastic bronchitis with nebulized tissue plasminogen activator: another brick in the wall
【2h】

Management of plastic bronchitis with nebulized tissue plasminogen activator: another brick in the wall

机译:雾化组织纤溶酶原激活剂治疗塑性支气管炎:另一堵墙

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Plastic bronchitis is a rare complication of a variety of respiratory diseases and congenital heart disease surgery, particularly Fontan procedure. Bronchial casts with rubber-like consistency develop acutely and may cause severe life-threatening respiratory distress. The management of plastic bronchitis is yet not well defined. Early intermittent, self-administered nebulization of tissue plasminogen activator was found to be effective in preventing deterioration of acute respiratory symptoms in a patient with primary ciliary dyskinesia and recurrent cast formation. Further investigation into new therapeutic strategies for this devastating disease is advocated.
机译:塑性支气管炎是各种呼吸系统疾病和先天性心脏病手术(尤其是丰坦手术)的罕见并发症。具有橡胶状稠度的支气管铸型会急剧发展,并可能导致严重的威胁生命的呼吸窘迫。塑性支气管炎的治疗方法尚未明确。人们发现,早期的组织纤维蛋白溶酶原激活剂的间歇性雾化可有效预防原发性睫状运动障碍和复发性铸型患者急性呼吸道症状的恶化。提倡对这种破坏性疾病的新治疗策略进行进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号